Mint Tower Capital Management B.V. »

Theravance Biopharma shares owned by Mint Tower Capital Management B.V.

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Mint Tower Capital Management B.V. from 13F filings

Historical chart of Mint Tower Capital Management B.V. investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Mint Tower Capital Management B.V. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Mint Tower Capital Management B.V.

Quarter filed Position value Share count Share price at filing
2026-06-30 $47k 2.8k 16.85

More positions owned by Mint Tower Capital Management B.V.

Lumentum Hldgs Note 0.500% 6/1 (Principal)
Lumentum Hldgs Note 0.500%12/1 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Stride Note 1.125% 9/0 (Principal)
SPDR KBW Regional Banking Call Option (KRE)
Uber Technologies (UBER)
Cyberark Software Note6/1 (Principal)
Launch Two Acquisition Corp. Ord Shs Cl A (LPBB)
Lafayette Digital Acquisitio Ord Class A (ZKP)
Art Technology Acquisition C Usd Cl A Ord Shs (ARTC)
Abony Acquisition Corp I Ord Shs Cl A
Silicon Vy Acquisition Corp Cl A (SVAQ)
Core Scientific *w Exp 01/23/202 (CORZW)
Hcm Iii Acquisition Corp Ord Shs Cl A (HCMA)

View all positions for Mint Tower Capital Management B.V.

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma